EU Market Surveillance: It’s About Rationalizing Resources, Not Seismic Changes
Executive Summary
The EU’s joint action on market surveillance, now a focus after the success of the joint action on notified bodies, is focusing on cooperation and avoiding duplication, rather than a step change, to achieve a safe EU. But it is early days and the key changes that will ultimately impact manufacturers will be announced further down the line.
You may also be interested in...
How EU's Competent Authority Group Is Flexing Its Muscles For New Roles
What do we know about the EU's Competent Authorities for Medical Devices group? It will have an important role in the implementation of the EU's new Regulations and in managing an EU market-surveillance project.
EU Institutions Reach Provisional Agreement On Proposed Health Data Regulation Amendments
Key changes have been agreed to the original European Commission text which would allow patients to opt out or restrict sharing of their information.
MedTech Europe Calls For Swift Answers In Areas Where AI Act Threatens MedTech
With the EU AI Act close to being finally adopted, industry is now calling for guidance and clarification to prevent the new legal text complicating the regulation of medical devices and diagnostics and putting obstacles in the way of patient access to innovation.